(Q26828418)

English

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

scientific article

In more languages

Statements

scholarly article

1 reference

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis (English)

1 reference

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

Claire Bombardier

15

0 references

Jasvinder Singh

object named as

Jasvinder A. Singh

1

0 references

Maxime Dougados

16

object named as

Maxime Dougados

1 reference

Jeffrey R Curtis

4

object named as

Jeffrey R. Curtis

1 reference

Kevin L Winthrop

9

object named as

Kevin L. Winthrop

1 reference

30

object named as

Kenneth G. Saag

1 reference

Timothy Beukelman

10

object named as

Timothy Beukelman

1 reference

author name string

Daniel E. Furst

2

1 reference

Aseem Bharat

3

1 reference

Arthur F. Kavanaugh

5

1 reference

Joel M. Kremer

6

1 reference

Larry W. Moreland

7

1 reference

James O'Dell

8

1 reference

S. Louis Bridges

11

1 reference

W. Winn Chatham

12

1 reference

Harold E. Paulus

13

1 reference

Maria Suarez-almazor

14

1 reference

Dinesh Khanna

17

1 reference

Charles M. King

18

1 reference

Amye L. Leong

19

1 reference

Eric L. Matteson

20

1 reference

John T. Schousboe

21

1 reference

Eileen Moynihan

22

1 reference

Karen S. Kolba

23

1 reference

Archana Jain

24

1 reference

Elizabeth R. Volkmann

25

1 reference

Harsh Agrawal

26

1 reference

Sangmee Bae

27

1 reference

Amy S. Mudano

28

1 reference

Nivedita M. Patkar

29

1 reference

language of work or name

1 reference

publication date

May 2012

1 reference

Arthritis Care and Research

1 reference

64

1 reference

5

1 reference

625-39

1 reference

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081542

7 April 2017

Tocilizumab for rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081542

7 April 2017

Golimumab for rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081542

7 April 2017

Biologics for rheumatoid arthritis: an overview of Cochrane reviews

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081542

7 April 2017

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...]

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081542

7 April 2017

Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081542

7 April 2017

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081542

7 April 2017

The Measurement of Observer Agreement for Categorical Data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081542

7 April 2017

Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081542

7 April 2017

American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081542

28 September 2017

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081542

28 September 2017

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081542

28 September 2017

A practical guide to scoring a Multi-Dimensional Health Assessment Questionnaire (MDHAQ) and Routine Assessment of Patient Index Data (RAPID) scores in 10-20 seconds for use in standard clinical care, without rulers, calculators, websites or compute

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081542

28 September 2017

The definition and measurement of disease modification in inflammatory rheumatic diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081542

28 September 2017

The American College of Rheumatology (ACR) Core Data Set and derivative "patient only" indices to assess rheumatoid arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081542

28 September 2017

Minimal disease activity for rheumatoid arthritis: a preliminary definition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081542

28 September 2017

Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081542

28 September 2017

Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081542

28 September 2017

Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081542

28 September 2017

Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081542

28 September 2017

Preventing joint damage as the best measure of biologic drug therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081542

28 September 2017

Sensitivity and specificity of the RAND/UCLA Appropriateness Method to identify the overuse and underuse of coronary revascularization and hysterectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081542

28 September 2017

Radiographic changes in early rheumatoid disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081542

28 September 2017

Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081542

31 May 2018

Developing quality indicators for elderly patients undergoing abdominal operations

1 reference

https://api.crossref.org/works/10.1002%2FACR.21641

21 January 2018

The appropriateness method

1 reference

https://api.crossref.org/works/10.1002%2FACR.21641

21 January 2018

Prognostic Value of Child-Turcotte Criteria in Medically Treated Cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FACR.21641

21 January 2018

The use of the New York Heart Association's classification of cardiovascular disease as part of the patient's complete Problem List.

1 reference

https://api.crossref.org/works/10.1002%2FACR.21641

21 January 2018

Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1002%2FACR.21641

21 January 2018

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

1 reference

https://api.crossref.org/works/10.1002%2FACR.21641

21 January 2018

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FACR.21641

21 January 2018

A simplified disease activity index for rheumatoid arthritis for use in clinical practice

1 reference

https://api.crossref.org/works/10.1002%2FACR.21641

21 January 2018

Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FACR.21641

21 January 2018

Adalimumab plus methotrexate improved SF-36 scores and reduced the effect of rheumatoid arthritis (RA) on work activity for patients with early RA.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4081542

28 November 2018

Infliximab treatment maintains employability in patients with early rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22473917

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of rheumatoid factor isotypes on disease activity and severity in patients with rheumatoid arthritis: a comparative study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22473917

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of employability outcomes among patients with early or long-standing rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22473917

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22473917

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on e

1 reference

https://pubmed.ncbi.nlm.nih.gov/22473917

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autoantibodies in rheumatoid arthritis: association with severity of disease in established RA

1 reference

https://pubmed.ncbi.nlm.nih.gov/22473917

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The disease activity score is not suitable as the sole criterion for initiation and evaluation of anti-tumor necrosis factor therapy in the clinic: discordance between assessment measures and limitations in questionnaire use for regulatory purposes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22473917

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A composite disease activity scale for clinical practice, observational studies, and clinical trials: the patient activity scale (PAS/PAS-II)

1 reference

https://pubmed.ncbi.nlm.nih.gov/22473917

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22473917

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/ACR.21641

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

release_teycp4y5zfefzc7wxpm2m2ryq4

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PMC publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26828418&oldid=1823658124"